REG - Oxford Biomedica PLC - Director Dealings
20/09/2023 11:45
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230920:nRST0914Na&default-theme=true
RNS Number : 0914N Oxford Biomedica PLC 20 September 2023
Director Dealings
Oxford, UK - 20 September 2023: Oxford Biomedica plc (LSE:OXB) ("Oxford
Biomedica" or "the Company"), a quality and innovation-led cell and gene
therapy CDMO, today announces the following share purchases by certain
Directors and Senior management.
Name of PDMR Number of ordinary shares purchased Number of ordinary shares now held Total number of ordinary shares held as a percentage of the Company's share
capital
Dr. Roch Doliveux 36,130 371,805 0.385%
Dr. Frank Mathias 20,000 20,000 0.020%
Stuart Paynter 4,030 18,687 0.019%
Leone Patterson 5,849 5,849 0.0061%
Catherine Moukheibir 7,226 25,756 0.027%
Stuart Henderson 1,000 10,862 0.011%
Sebastien Ribault* 1,500 - -
Nick Page* 11,678 - -
Matthew Treagus* 3,842 - -
James Miskin* 1,808 - -
*Senior Management
The below notifications, made in accordance with the requirements of the EU
Market Abuse Regulation, give further details of the number of ordinary shares
purchased.
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Dr. Roch Doliveux
2. Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.7430 36,130
e) Aggregated information
- Aggregate volume 36,130
- Aggregated total
£99,104.59
f) Date of the transaction 2023-09-20; 10:27
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
36,130
£99,104.59
f)
Date of the transaction
2023-09-20; 10:27
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Dr. Frank Mathias
2. Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.7498 20,000
e) Aggregated information
- Aggregate volume 20,000
- Aggregated total
£54,996
f) Date of the transaction 2023-09-20; 10:26
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
20,000
£54,996
f)
Date of the transaction
2023-09-20; 10:26
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Stuart Paynter
2. Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.481 4,030
e) Aggregated information
- Aggregate volume 4,030
- Aggregated total
£9,998.43
f) Date of the transaction 2023-09-20; 08.01
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
4,030
£9,998.43
f)
Date of the transaction
2023-09-20; 08.01
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Leone Patterson
2. Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.7445 5,849
e) Aggregated information
- Aggregate volume 5,849
- Aggregated total
£16,052.58
f) Date of the transaction 2023-09-20; 10:28
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
5,849
£16,052.58
f)
Date of the transaction
2023-09-20; 10:28
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Catherine Moukheibir
2. Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.7430 7,226
e) Aggregated information
- Aggregate volume 7,226
- Aggregated total
£19,820.92
f) Date of the transaction 2023-09-20; 10:28
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
7,226
£19,820.92
f)
Date of the transaction
2023-09-20; 10:28
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Stuart Henderson
2. Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.7497 1,000
e) Aggregated information
- Aggregate volume 1,000
- Aggregated total
£2,749.70
f) Date of the transaction 2023-09-20; 10:26
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
1,000
£2,749.70
f)
Date of the transaction
2023-09-20; 10:26
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Sebastien Ribault
2. Reason for the notification
a) Position/status Chief Commercial Officer
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.7497 1,500
e) Aggregated information
- Aggregate volume 1,500
- Aggregated total
£4,124.55
f) Date of the transaction 2023-09-20; 10:27
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
1,500
£4,124.55
f)
Date of the transaction
2023-09-20; 10:27
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Nick Page
2. Reason for the notification
a) Position/status Chief Operations Officer
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.555 11,678
e) Aggregated information
- Aggregate volume 11,678
- Aggregated total
£29,837.29
f) Date of the transaction 2023-09-20; 08.08
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
11,678
£29,837.29
f)
Date of the transaction
2023-09-20; 08.08
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name Matthew Treagus
2. Reason for the notification
a) Position/status Chief Information Officer and Chief of Staff
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.587949 3,842
e) Aggregated information
- Aggregate volume 3,842
- Aggregated total
£9,942.90
f) Date of the transaction 2023-09-20; 08.05
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
3,842
£9,942.90
f)
Date of the transaction
2023-09-20; 08.05
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1. Details of the Person Discharging Managerial Responsibility ("PDMR")
a) Name James Miskin
2. Reason for the notification
a) Position/status Chief Technical Officer
b) Initial notification/ Initial Notification
amendment
3. Details of the Issuer
a) Name Oxford Biomedica plc
b) LEI code 213800S1GVQNXQ15K851
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary Shares of 50 pence each
Identification code
ISIN: GB00BDFBVT43
b) Nature of the transaction Purchase of shares
c) Currency GBP - British pound
d) Price(s) and volumes(s)
Price(s) Volume(s)
£2.74 1,808
e) Aggregated information
- Aggregate volume 1,808
- Aggregated total
£4,953.92
f) Date of the transaction 2023-09-20; 10:55
g) Place of the transaction London Stock Exchange, Main Market (XLON)
e)
Aggregated information
- Aggregate volume
- Aggregated total
1,808
£4,953.92
f)
Date of the transaction
2023-09-20; 10:55
g)
Place of the transaction
London Stock Exchange, Main Market (XLON)
-Ends-
For further information, please contact:
Oxford Biomedica plc: Tel: +44 (0)1865 783 000
Natalie Walter, Company Secretary
About Oxford Biomedica
Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene
therapy CDMO with a mission to enable its clients to deliver life changing
therapies to patients around the world.
One of the original pioneers in cell and gene therapy, the Company has more
than 25 years of experience in viral vectors; the driving force behind the
majority of gene therapies. The Company collaborates with some of the world's
most innovative pharmaceutical and biotechnology companies, providing viral
vector development and manufacturing expertise in lentivirus, adeno-associated
virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class
capabilities span from early-stage development to commercialisation. These
capabilities are supported by robust quality-assurance systems, analytical
methods and depth of regulatory expertise.
Oxford Biomedica, a FTSE4Good constituent, is headquartered in Oxford, UK. It
has locations across Oxfordshire, UK and near Boston, MA, US. Learn more at
www.oxb.com (https://www.oxb.com/) , www.oxbsolutions.com
(https://oxbsolutions.com/) , and follow us on LinkedIn
(https://www.linkedin.com/company/oxford-biomedica/) and YouTube
(https://www.youtube.com/user/OxfordBioMedica) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHDZGZLGGGGFZMRecent news on Oxford BioMedica
See all newsREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - 2023 Annual Report and Accounts
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Update on CDMO Services
AnnouncementREG - Oxford Biomedica PLC - Board Changes
Announcement